首页> 外文OA文献 >Treatment of cows with parturient paresis using intravenous calcium and oral sodium phosphate
【2h】

Treatment of cows with parturient paresis using intravenous calcium and oral sodium phosphate

机译:静脉钙和口服磷酸钠治疗产后轻瘫的母牛

摘要

The goal of this study was to investigate whether intravenous infusion of 1000 ml 40% calcium borogluconate combined with the oral adminstration of 500 g sodium phosphate leads to a better cure rate and longer-lasting normocalcaemia and normophosphataemia than standard intravenous treatment with 500 ml calcium borogluconate in cows with parturient paresis. Forty recumbent cows with hypocalcaemia and hypophosphataemia were alternately allocated to group A or B. Cows of both groups were treated intravenously with 500 ml 40% calcium borogluconate, and cows of group B additionally received another 500 ml calcium borogluconate via slow intravenous infusion and 500 g sodium phosphate administered via an orogastric tube. Thirty-two cows stood within 8 hours after the start of treatment and 8 did not; of the 32 cows that stood, 18 belonged to group A and 14 to group B (90% of group A vs. 70% of group B; P = 0.23). Seven cows relapsed; of these and the 8 that did not respond to initial treatment, 10 stood after two standard intravenous treatments. Downer cow syndrome occurred in 5 cows, 3 of which recovered after aggressive therapy. The overall cure rate did not differ significantly between groups A and B. Twelve (60%) cows of group A and 14 (70%) cows of group B were cured after a single treatment and of the remaining 14, 11 were cured after two or more treatments. Two downer cows were euthanized and one other died of heart failure during treatment. Serum calcium concentrations during the first eight hours after the start of treatment were significantly higher in group B than in group A, and oral sodium phosphate caused a significant and lasting increase in inorganic phosphate. More cows of group B than group A were cured after a single treatment (P > 0.05). These findings, although not statistically significant, are promising and should be verified using a larger number of cows.
机译:这项研究的目的是研究与500 ml硼葡萄糖酸钙的标准静脉内治疗相比,静脉输注1000 ml 40%硼葡萄糖酸钙与500 g磷酸钠的口服给药是否能带来更好的治愈率和更长的正常血钙和正常血磷血症。有产后轻瘫的奶牛。将40例低钙血症和低磷酸血症的卧位母牛交替分配至A组或B组。两组母牛均接受500 ml 40%硼葡萄糖酸钙静脉内治疗,B组母牛还通过缓慢静脉输注和500 g再次获得500 ml硼葡萄糖酸钙。通过口胃管给药的磷酸钠。在开始治疗后的8小时内,有32头母牛站立,而8头则没有。在站立的32头母牛中,有18头属于A组,而14头属于B组(A组的90%比B组的70%; P = 0.23)。七头牛复发了;其中8例对初始治疗无反应,10例经过两次标准静脉内治疗。下母牛综合症发生在5头母牛中,其中3头在积极治疗后得以恢复。 A组和B组的总治愈率没有显着差异。A组的十二头(60%)母牛和B组的14头(70%)母牛在一次治疗后treatment愈,其余的14头,11头在两次治疗后cured愈。或更多治疗。在治疗过程中,对两头唐纳德牛进行了安乐死,另一只因心力衰竭死亡。在治疗开始后的前八小时内,B组的血清钙浓度显着高于A组,口服磷酸钠引起无机磷酸盐的显着且持久的增加。一次治疗后,B组的母牛治愈率高于A组(P> 0.05)。这些发现尽管没有统计学意义,但很有希望,应使用更多的母牛进行验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号